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Abstract
Background: Very little is known about the prevalence of ADHD symptoms in Bulimia Nervosa and Binge Eating
Disorder and even less in other eating disorders. This knowledge gap is of clinical importance since stimulant
treatment is proven effective in Binge Eating Disorder and discussed as a treatment possibility for Bulimia Nervosa.
The objective of this study was to explore the prevalence and types of self-reported ADHD symptoms in an
unselected group of eating disorder patients assessed in a specialized eating disorder clinic.
Methods: In total 1165 adults with an eating disorder were assessed with a battery of standardized instruments, for
measuring inter alia ADHD screening, demographic variables, eating disorder symptoms and psychiatric
comorbidity. Chi-square tests were used for categorical variables and Kruskal-Wallis tests for continuous variables.
Results: Almost one third (31.3 %) of the patients scored above the screening cut off indicating a possible ADHD.
The highest prevalence rates (35–37 %) were found in Bulimia Nervosa and Anorexia Nervosa bingeing/purging
subtype, while Eating Disorder Not Otherwise Specified type 1–4 and Binge Eating Disorder patients reported
slightly below average (26–31 %), and Anorexia Nervosa restricting subtype patients even lower (18 %). Presence of
binge eating, purging, loss of control over eating and non-anorectic BMI were related to results indicating a
possible ADHD. Psychiatric comorbidity correlated to ADHD symptoms without explaining the differences between
eating disorder diagnoses.
Conclusions: There is a high frequency of ADHD symptoms in patients with binge eating/purging eating disorders
that motivates further studies, particularly concerning the effects of ADHD medication. The finding that the
frequency of ADHD symptoms in anorexia nervosa with binge eating/purging is as high as in bulimia nervosa
highlights the need also for this group.
Keywords: ADHD, Anorexia nervosa, Binge eating disorder, Bulimia nervosa, Comorbidity, Eating disorders,
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Background
Very little is known about the prevalence of Attention
Deficit Hyperactivity Disorder (ADHD) symptoms in
Bulimia Nervosa (BN) and Binge Eating Disorder (BED)
and even less in other eating disorders (ED) [1]. This
knowledge gap is of clinical importance, not least since
stimulant treatment is proven effective in BED [2, 3] and
discussed as a treatment possibility for BN [4, 5].
Both ED and ADHD are common and serious disorders
with longstanding debilitating symptoms
The lifetime prevalence of ED for females has been esti-
mated to 0.9 % for Anorexia Nervosa (AN), 1.5 % for BN
and 3.5 % for BED [6]. In a review article the mortality
rate per 1000 person-years was 5.1 (95 % CI: 3.99–6.14)
for AN, and 1.74 (95 % CI: 1.09–2.44) for BN; the 5-year
recovery rates were 69 % for AN and 55 % for BN,
respectively [7]. Females strongly outnumbers males in
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clinical samples for most ED diagnoses, except for BED
where the sex ratio is less extreme [8]. Restricting ED
dominate during childhood and bulimic in adulthood [9].
Furthermore there is a high comorbidity of other psychi-
atric disorders in ED [10, 11].
For ADHD, one meta-analysis estimated the preva-
lence to 5.9–7.1 % for children and adolescents and 5 %
for young adults [12]. ADHD is classified into three
types: hyperactive, inattentive, and combined. The in-
attentive type is more common among girls compared
to boys [13]. In general, the course of ADHD includes a
decrease in symptoms of hyperactivity and impulsivity,
while inattention persists over time [14]. Detection and
diagnosis tend to be later and less frequent in females
than in males, probably related to the observed lower
levels of extroversion and aggression in females [13].
Girls diagnosed with ADHD are also less likely to be
treated with medication than boys [15]. The awareness
among clinicians that ADHD exists in adulthood is also
often limited [16]. The co-existence of ADHD and ED is
thus easily overlooked. Due to the skewed gender distri-
bution where females outnumbers males in ED, this
could lead to a significant underestimation of ADHD in
ED populations.
There is an overlap in prevalence and treatment response
between ADHD and ED
Regarding prevalence, a review concluded that females
with ADHD had a higher risk of developing ED; BN
rates found in ADHD ranged between 1 and 12 % versus
0–2 % in control groups [17]. In a cross-sectional study
the prevalence of BED in ADHD was 8.1 % compared
with 2.6 % in the general population [18]. Seitz et al. [5]
found prevalence rates of former childhood ADHD to be
21 % in patients with BN versus 2.5 % in matched
healthy controls. Blinder et al. [10] found co-morbid
ADHD in 6 % of a large retrospective sample of 2436
female ED inpatients. Yates, Lund, Johnson, Mitchell, &
McKee [19] found that 21 % of 189 inpatient females
with ED reported at least six current ADHD symptoms.
Wentz et al. [20] found that 17 % of a small sample (n =
30) of longstanding (mean 9.5 years; 95 % CI 6.2–12.8)
ED fulfilled criteria of ADHD with both current and
childhood symptoms. In a nationally representative sam-
ple, the occurrence of ADHD in young girls was associ-
ated with subsequent ED for females and with binging
and/or purging behavior but not with restrictive behav-
ior [21]. ED and ADHD share problems with impulsivity,
depression, anxiety and low self-esteem and a causal
chain has been proposed where the ADHD problems
contribute to development of ED [22].
With respect to overlap in treatment response between
ADHD and BN/BED, several case reports have observed
a rapid and significant reduction of binge eating and
purging symptoms when patients with coexisting BN/
BED and ADHD were treated with stimulants [23–29].
Three possible explanations for this observed effective-
ness of stimulant treatment for BN are discussed by
Dukarm [25]: a) A common pathophysiology between
ADHD and BN. One hypothesis is that dysregulated
dopamine systems in both ADHD and BN/BED leads to
risky behaviors (e.g. gambling, substance abuse or binge
eating) to enhance the reward system. b) Untreated
ADHD pave the way for BN (see above). and c) The
appetite-suppressing effect of stimulants decreases the
desire to binge and purge. In this case the effect of stim-
ulants on BN/BED would be independent of a comorbid
ADHD. Some support for this is found in a small
double-blind placebo controlled study on 8 BN patients,
without known ADHD, treated with intravenous methy-
lamphetamine. Despite the small sample size methylam-
phetamine significantly reduced binge eating and
purging [30]. In addition, in two randomized studies lis-
dexamfetamine reduced symptoms of binge eating in
adults with BED, even while excluding those with previ-
ously known ADHD [2, 3].
Given the high prevalence and debilitating symptoms
of bulimic ED and ADHD, and their substantial overlap,
both in terms of prevalence and treatment response, it is
important to further explore the relationship between
these conditions. The lower likelihood of ADHD detec-
tion and stimulant treatment in females compared to
males could also, in combination with the skewed gen-
der distribution, contribute to increased prevalence rates
of and impaired treatment results in bulimic ED. We ex-
amined the relationship between ED and ADHD symp-
toms in adults of both genders using prospectively
collected quality register data covering the full range of
ED diagnoses.
Aim
One aim of this study was to explore the prevalence and
types of self-reported ADHD symptoms in a large, unse-
lected group of ED patients assessed in a specialized ED
clinic. Another aim was to investigate the relations between
ADHD symptoms and ED diagnoses and symptoms.
The specific questions addressed were: a) what is the
prevalence of self-reported ADHD symptoms in severe
ED? b) do the prevalence and types of self-reported
ADHD symptoms differ between ED diagnoses and
symptoms? and c) is the relationship between ADHD
symptoms and ED diagnoses influenced by depressive,
anxious or obsessive-compulsive symptoms?
Methods
Participants
As displayed in Fig. 1, 1527 adult consecutive patients
were seeking help at the Stockholm Centre for Eating
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Disorders (SCED) from 4 February 2013 through 18
September 2015. Of these, 61 did not consent to partici-
pate in research, 210 did not fulfil DSM-IV criteria for
an eating disorder diagnosis and another 91 were ex-
cluded due to incomplete data. Of the remaining, 47
were males. Due to their documented differences in ADHD
symptoms compared to females, with a risk of confounding
the results, males are described separately and not included
in the statistical analyses. The small (n = 24) Eating Disorder
Not Otherwise Specified (EDNOS) type 5 group has differ-
ent and unusual symptoms compared to all other ED diag-
noses and was therefore also not included in the statistical
analyses, thus leaving a total of 1094 female participants to
analyze. Descriptive data including males and EDNOS type
5 are presented in Table 1.
Participants were between 18 and 70 years of age
(mean 27.7; SD 8.7) with BMI ranging from 11.6 to 60.4
(mean 23.3; SD 6.3). In total 41 % were living alone or
with own children (below 18 years age) and 88 % were
working or studying on the open market (Table 1).
Measures
All participants were assessed with Stepwise, a web-based
quality assurance system for clinical ED care [31]. From
Stepwise we used data from the Structured Eating Dis-
order Interview (SEDI) [32] for ED diagnoses according to
the DSM, fourth edition, Text Revision (DSM-IV TR). To
facilitate the analyses we grouped the diagnoses as strin-
gent as possible out from restricting, bingeing and purging
symptoms, i.e. AN restricting subtype (AN-R), AN
bingeing/purging subtype (AN-BP), BN purging and non-
purging type (BN), EDNOS type 1–2 [EDNOS-R (R =
restricting)], EDNOS type 3–4 [EDNOS-BP (BP = binge-
ing/purging)], EDNOS type 5, and BED that is classified as
EDNOS type 6 in DSM-IV TR. SEDI also identifies
individual patients with binge eating, purging and loss of
control over eating. Preliminary validation of SEDI against
the internationally extensively validated Eating Disorder
Examination [33], interview has shown a concordance of
81 % for specific ED diagnosis and a Kendall’s Tau-b of
0,69 (p < 0.0001) [32]. Further, we used demographic data
from Riksät, the national quality register for ED treatment
[34]. From Stepwise we also used the Comprehensive
Psychiatric Rating Scale (CPRS) a self-report instrument
for depression, anxiety and obsession-compulsion [35].
The correlation between the self-ratings and interview rat-
ings based on the Montgomery-Åsberg Depression Rating
Scale and Brief Scale for Anxiety has been reported to be
above 0.87 and 0.80 respectively [35]. For this study the
screening version of the WHO ADHD Self-Rating Scale
for Adults (ASRS-screener) for ADHD symptoms was
added to Stepwise. This instrument consists of four
questions addressing attention deficit symptoms and two
questions for hyperactivity/impulsivity symptoms. Each
question has five response alternatives; never, rarely,
sometimes, often and very often, graded from 0 to 4 [36].
The total sum was used as the ASRS trait score (ASRSTS;-
range 0–24) and the dichotomized scale (0-13/14-24) for
identifying possible cases of ADHD [37]. The four
attention deficit and the two hyperactivity/impulsivity
questions were also used separately as an inattention trait
score (ITS; range 0–16) and a hyperactivity trait score
(HTS; range 0–8) as proposed by Das, Cherbuin, Butter-
worth, Anstey & Easteal [38]. According to Kessler et al.
[37], internal consistency reliability of the ASRS screener
was in the range 0.63-0.72. In the current study, the
Cronbach alpha coefficient for the ASRS screener was
1527 patients 61 research 
denied
1466 patients 210 no ED
1256 patients 91 incomplete 
data





Fig. 1 Patient flowchart
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0.82, with the subscales showing similar figures (ITS =
0.84 and HTS = 0.73).
Statistical analysis
All analyses were performed with IBM SPSS Statistics
version 23. Although the Kolmogorov-Smirnov statistics
were significant for all continuous parameters they were
all fairly normally distributed as concluded from histo-
grams. Preliminary analyses were performed and re-
vealed no major violation of assumptions of linearity,
homogeneity of variances, homogeneity of regression
slopes or homoscedasticity. Non-parametric tests were
chosen since ASRS and CPRS do not fulfil criteria for an
interval scale, and since group sizes for the different ED
diagnoses varied considerably, which at least to some ex-
tent could compromise the assumption of normality.
Chi-square tests for independence were used to analyze
the dichotomized ASRS- (0-13/14-24) scale versus ED
diagnoses and ED symptoms, respectively. Kruskal-
Wallis tests were done to compare ASRS trait score,
ITS, HTS and CPRS scores between ED diagnoses, with
follow-up Mann–Whitney U tests with Bonferroni cor-
rections to analyse group differences for ASRS trait
score and CPRS between AN-R and bingeing/purging
ED (AN-BP, BN, EDNOS-BP, BED). Spearman rho cor-
relation analyses were done between the three CPRS
scales (dep., anx. and com.) and ASRS trait score. All
significance tests were two tailed; alpha-level of 5 %.
Results
Prevalence of self-reported ADHD symptoms
The prevalence of ASRS-screener results indicating a
possible ADHD (ASRS trait score ≥14) was 31.6 % in
females (n = 1094). For the groups not included in further
analyses, corresponding results were 34.0 % for men and
12.5 % for patients belonging to the EDNOS type 5 group,
resulting in a prevalence of ASRS-screener results indicat-
ing a possible ADHD of 31.3 % in the whole patient group
(n = 1165). (Table 2).
Differences in self-reported ADHD symptoms between ED
diagnoses and symptoms
The highest frequency of possible ADHD was found in
BN and in AN-BP, respectively. The EDNOS-BP, BED
and EDNOS-R patients had intermediate frequencies
and AN-R had the lowest. The difference in ASRS trait
score ≥14 across ED diagnoses was significant with a
small to medium effect size [χ2 (5, n = 1094) = 15.30, p =
0.009, Cramer’s V = 0.12] (Table 3).
Kruskal-Wallis tests revealed statistically significant
differences across ED diagnoses for ASRS trait score [χ2
(5, n = 1094) = 31.89, p = 0.000], inattention trait score
(ITS) [χ2 (5, n = 1094) = 40.90, p = 0.000] and hyperactiv-
ity trait score (HTS) [χ2 (5, n = 1094) = 12.84, p = 0.025].
Four Mann–Whitney U Tests each for ASRS trait score,
ITS and HTS, were done pairwise comparing AN-R with
all bingeing/purging ED groups (AN-BP, BN, EDNOS-BP
and BED). This revealed significant differences for ASRS
trait score in all tested pairs besides AN-R/AN-BP (r =
0.19-0.25), for ITS in all tested pairs (r = 0.19–0.32), and
for HTS only between AN-R and EDNOS-BP (r = 0.13).
ASRS trait score and ITS recorded highest median score
in the BN group (Md = 12 and 8, respectively) and lowest
median score in AN-R (Md = 7 and 5 respectively). HTS
recorded the highest median score 5 in AN-BP and the
lowest median score 3 in AN-R and BED (Table 4).
When further exploring the association to ED symp-
toms, ASRS ≥14 was found to be positively related to
binge eating [χ2 (1, n = 1094) = 8.08, p = 0.004, Phi = 0.09],
purging [χ2 (1, n = 1094) = 8.52, p = 0.004, Phi = 0.09], loss
Table 1 Demographic data across ED diagnoses and gender




Females 1118 27.6 (8.6) 23.1 (6.0) 40.5 (394/973) 88.1 (966/1096)
AN-R 68 23.2 (6.6) 15.8 (1.4) 22.7 (15/66) 81.8 (54/66)
AN-BP 37 24.1 (6.2) 16.3 (0.9) 21.2 (7/33) 86.5 (32/37)
EDNOS-R 148 26.3 (8.1) 21.3 (5.8) 39.1 (54/138) 84.9 (124/146)
BN 421 27.6 (7.7) 23.8 (4.6) 45.1 (167/370) 90.2 (370/410)
EDNOS-BP 329 27.4 (8.1) 22.9 (4.6) 39.9 (110/276) 89.9 (294/327)
BED 91 34.2 (11.8) 33.0 (6.9) 51.5 (34/66) 83.0 (73/88)
EDNOS 5 24 29.8 (13.2) 20.1 (4.1) 29.2 (7/24) 86.4 (19/22)
Males 47 31.5 (10.9) 28.1 (9.9) 42.5 (17/40) 89.4 (42/47)
Total 1165 27.7 (8.7) 23.3 (6.3) 40.6 (411/1013) 88.2 (1008/1143)
ain-complete data, bliving alone or with own children (below 18 years age), cworking/studying on the open market
AN-R (Anorexia Nervosa restricting subtype), AN-BP (Anorexia Nervosa bingeing/purging subtype), EDNOS (Eating Disorder not otherwise specified), BN (Bulimia
Nervosa purging and non-purging subtype), BED (Binge Eating Disorder = EDN 6)
SD (Standard deviation), n (number with criteria), N (Number in ED group analysed)
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of control over the eating [χ2 (1, n= 1094) = 5.51, p= 0.019,
Phi = 0.07] and BMI > 17.5 [χ2(1, n= 1094) = 4.44, p= 0.035,
Phi = 0.07].
Influence of depressive, anxious or obsessive-compulsive
symptoms on difference between ED diagnoses in self-
reported ADHD
ASRS trait score had a medium strong positive cor-
relation with the CPRS scales for depression (rho =
0.38, p <0.001), anxiety (rho = 0.42, p <0.001) and
obsession-compulsion (rho = 0.45, p <0.001), respect-
ively. Kruskal-Wallis tests revealed statistically significant
differences across ED diagnoses for CPRS-dep. [χ2 (5, n=
1094) = 13.15, p= 0.022] but not for CPRS-anx. (p= 0.245)
or CPRS-com. (p= 0.208). Four Mann–Whitney U Tests for
CPRS-dep. pairwise comparing AN-R with all bingeing/pur-
ging ED groups (AN-BP, BN, EDNOS-BP and BED)
revealed no significant differences (Table 4).
Discussion
Prevalence of self-reported ADHD symptoms
In this consecutive series of adults seeking help at a large
specialized ED clinic, the ASRS-screener was above cut-
off (≥14), indicating a possible ADHD, in almost one third
(31.3 %) of the entire patient group (n = 1165). This preva-
lence is high compared to estimates of ADHD frequency
in ED in previous studies: 5.3–21 % [5, 10, 19, 20].
Differences in self-reported ADHD symptoms between ED
diagnoses and symptoms
A marked difference was seen in the frequency of
ADHD symptoms between the ED diagnoses. The
ASRS-screener indicated a possible ADHD about twice
as often in BN patients as in AN-R. AN-BP had ASRS-
screener levels almost as high as BN, which to our
knowledge is not shown before. EDNOS-BP, BED and
EDNOS-R patients had intermediate frequencies of
ASRS-screener results above the cut-off level (≥14). Al-
though AN-R had a low frequency indicating a possible
ADHD in our study (17.6 %), it was still high compared
to previous findings of 3 % [10] and also compared to
ADHD prevalence among young adults in society 5 %
[12]. A possible explanation of this high frequency might be
that the ASRS-screener tends to overestimate symptoms of
ADHD in this population. This underlines the need for a
validation study of ASRS in an ED population. The current
finding of a very high level of ASRS-screener scores indicat-
ing ADHD in AN-BP is in line with the observation in the
study of a group with longstanding ED (mean 9.5 years;
95 % confidence interval 6.2–12.8) by Wentz et al. [20], that
ADHD was found in AN-BP but not in AN-R. AN-BP is as-
sumed to be prognostic unfavourable [39] and thus in great
need for new treatment possibilities.
The analysis of ED symptoms indicated a significant
positive relation between ASRS ≥14 and the presence of
binge eating/purging behaviors, loss of control over eating
and BMI > 17.5, however with small effect sizes limiting
the interpretation of these findings. Our results were in
accordance with a recent study, including a nationally rep-
resentative sample, which showed that clinical ADHD was
associated with clinical bingeing/purging [40].
Our finding that the ITS had a stronger relationship
with ED than the HTS has previously been shown to be
the case in adult ADHD where the hyperactivity/impul-
sivity symptoms are less prominent than among children
and adolescents [19]. However both attention deficit and
hyperactivity/impulsivity symptoms of ADHD are of im-
portance for the comorbidity with ED. One possible ex-
planation of this might be that loss of control is a
central issue that co-varies with both ADHD and ED. In-
attention can lead to confusion and impulsivity/hyper-
activity can cause ill-considered actions, which both can
contribute to loss of control. This possible common fac-
tor seems to be primarily associated with binge eating
and purging behaviors. In clinical work it is also obvious
Table 2 Clinical features
Femalesa Males EDNOS 5
Number 1094 47 24
ASRS-screener ≥14 n (%) 346 (31.6) 16 (34.0) 3 (12.5)
ITS mean (SD) 6.95 (3.94) 7.47 (4.10) 6.17 (2.70)
HTS mean (SD) 3.85 (2.20) 3.96 (2.20) 3.42 (1.74)
Bingeing n (%) 740 (67.6) 36 (76.6) 10 (41.7)
Purging n (%) 544 (49.7) 17 (36.2) 4 (16.7)
Loss of control over eating n (%) 859 (78.5) 35 (74.5) 11 (45.8)
BMI > 17.5 n (%) 968 (88.5) 47 (100) 18 (75.0)
CPRS dep mean (SD) 10.56 (4.57) 9.97 (4.88) 9.17 (3.85)
CPRS anx mean (SD) 9.67 (4.19) 8.65 (4.54) 8.54 (3.30)
CPRS com mean (SD) 9.16 (4.25) 8.28 (4.78) 9.10 (4.47)
aexcluding EDNOS 5. ASRS (The World Health Organization adult ADHD self-report
scale)-screener (range 0–24), ITS (Inattention trait score; range 0–16), HTS
(Hyperactivity trait score; range 0–8), CPRS (Comprehensive Psychiatric rating
scale), dep (depression; range 0–27), anx (anxiety; range 0–27), com (obsession-
compulsion; range 0–24)
Table 3 ASRS-screener ≥14 across ED diagnoses in females
AN-R AN-BP EDNOS-R BN EDNOS-BP BED Total pa Cramer’s V
% (n/N) 17.6 % (12/68) 35.1 % (13/37) 25.7 % (38/148) 37.1 % (156/421) 31.0 % (102/329) 27.5 % (25/91) 31.6 % (356/1094) <0.01 0,12
aChi-square (two-sided), n (number with ASRS-screener ≥14), N (number in this ED group)
ASRS (The World Health Organization adult ADHD self-report scale)-screener (0-13/14-24)
AN-R (Anorexia Nervosa restricting subtype), AN-BP (Anorexia Nervosa bingeing/purging subtype), EDNOS (Eating Disorder not otherwise specified), BN (Bulimia
Nervosa purging and non-purging subtype), BED (Binge Eating Disorder = EDNOS 6)
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that AN patients, despite the primary impression of ex-
treme control over the eating, tend to themselves experi-
ence a more or less total uncertainty about the adequacy
of their food intake, due to their anorectic obsessions,
resulting in loss of control.
Influence by depressive, anxious or obsessive-compulsive
symptoms on difference between ED diagnoses in self-
reported ADHD
The medium strong correlations between the ASRS trait
score and depression, anxiety and obsession-compulsion
respectively, estimated with CPRS, are in line with the
high psychiatric comorbidity for depression and anxiety
in both ADHD [41] and ED [10, 11]. However, for the
three CPRS variables, there were significant differences
across ED diagnoses only for CPRS-depression and pair-
wise comparisons between AN-R and the four bingeing/
purging ED diagnoses (AN-BP, BN EDNOS-BP and
BED) did not show significant differences for CPRS de-
pression. Accordingly, the CPRS variables cannot fully
explain the differences in ASRS trait score between ED
diagnoses.
Males and EDNOS 5
There were too few males and females with an EDNOS
type 5 diagnosis in the study to include them in any
meaningful statistical analyses. However, it seems as if
the frequency of possible ADHD among men is on the
same level as among the bingeing/purging females, while
it seems to be much lower than in any other group
among the EDNOS type 5 patients.
“Knowledge and knowledge gaps”
ED and ADHD share many symptoms [22] and the two-
fold differences in ASRS screener results between ED
diagnoses indicate that these shared symptoms are
mainly related to bingeing and purging ED symptoms.
Effect sizes for these differences were small to medium
supporting an assumption of other differentiating factors
besides symptoms shared with ADHD.
There is a great need to conduct research aimed at
better understanding the nature of the association be-
tween ADHD and ED. Because of the methodological
limitations, it would also be very useful if this study
could be replicated using more detailed assessments of
ADHD symptoms in as large a sample as possible.
Table 4 Pairwise Mann–Whitney U Tests AN-R across binge-/purging ED and median scores across ED groups
Median score U Z p r
AN-R ASRSTS 7
AN-BP (vs. AN-R) ASRSTS 11 910 −2.34 0.019 0.23
BN (vs. AN-R) ASRSTS 12 8942 −4.98 0.000* 0.23
EDNOS-BP (vs. AN-R) ASRSTS 10 7922 −3.80 0.000* 0.19
BED (vs. AN-R) ASRSTS 10 2187 −3.17 0.002* 0.25
AN-R ITS 5
AN-BP (vs. AN-R) ITS 7 855 −2.72 0.007* 0.26
BN (vs. AN-R) ITS 8 8480 −5.41 0.000* 0.24
EDNOS-BP (vs. AN-R) ITS 6 7982 −3.73 0.000* 0.19
BED (vs. AN-R) ITS 7 1930 −4.07 0.000* 0.32
AN-R HTS 3
AN-BP (vs. AN-R) HTS 5 1033 −1.53 0.127 0.15
BN (vs. AN-R) HTS 4 11801 −2.34 0.019 0.11
EDNOS-BP (vs. AN-R) HTS 4 8995 −2.57 0.010* 0.13
BED (vs. AN-R) HTS 3 2959 −0.47 0.635 0.04
AN-R CPRS-dep 9.5
AN-BP (vs. AN-R) CPRS-dep 11.5 955 −2.03 0.042 0.06
BN (vs. AN-R) CPRS-dep 11.0 11901 −2.23 0.026 0.07
EDNOS-BP (vs. AN-R) CPRS-dep 10.0 9947 −1.44 0.150 0.04
BED (vs. AN-R) CPRS-dep 10.0 2763 −1.16 0.248 0.04
* = sign. (when applying a Bonferroni adjustment of 0.05/4 = 0.013 to the alpha values)
ASRSTS (The World Health Organization adult ADHD self-report scale trait score; range 0–24), ITS (Inattention trait score; range 0–16), HTS (Hyperactivity trait score;
range 0–8), CPRS-dep (Comprehensive Psychiatric rating scale for depression; range 0–27). AN-R (Anorexia Nervosa restricting subtype), AN-BP (Anorexia Nervosa
bingeing/purging subtype), EDNOS-BP (Eating Disorder not otherwise specified bingeing/purging subtype), BN (Bulimia Nervosa purging and non-purging subtype),
BED (Binge Eating Disorder = EDNOS 6)
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There are cumulating evidence of a good effect on bu-
limic symptoms when comorbid ADHD is treated with
stimulants [23–29]. In addition, two recently published
randomized multicenter studies showed that the stimu-
lant lisdexamfetamine reduced symptoms of binge eating
in adults with BED, even while excluding those with pre-
viously known ADHD diagnosis [2, 3]. In the study by
Bleck et al. [40] subclinical ADHD, both inattentive and
hyperactive/impulsive, was associated with subclinical
bingeing/purging but not with restricting behaviors. To-
gether this raises the question whether degree of ADHD
symptoms, confirmed ADHD diagnosis or actual ED
symptoms are the most important parameters to guide
clinical decisions concerning stimulant medication in
adult ED patients. This motivates further randomized tri-
als with stimulant treatment for bingeing/purging ED-
patients with and without a concomitant ADHD diagno-
sis. The finding of ADHD symptoms in AN-BP as high as
in BN evoke the question if it is possible to try stimulant
medication also in this group, if proven effective for BN.
However the risk due to appetite suppression in an under-
weight patient must be taken into consideration. Another
possible approach for deepened understanding could be a
longitudinal study to investigate how treatment for ED in-
teracts with ADHD symptoms and vice versa.
Strengths and limitations
There are several strengths with this study to mention.
First, the cohort constitutes the total intake of adult
patients in a single clinic for a certain period of time.
Second, the study sample is comparably large. Third, the
study sample is recruited during an extended time
period (31 months) minimizing confounding from time
dependent differences. Fourth, there is no demand for
an admission note. Fifth, men are included. Altogether,
we suggest these results to be representative for adult
patients searching help at a specialized ED clinic.
However, there are some limitations of this study to
consider. First, an ADHD diagnosis postulate the pres-
ence of ADHD symptoms since childhood. The ASRS
scale used in the present study only records ADHD
symptoms during the last six months, probably resulting
in an overestimation of ADHD prevalence. Second, the
use of a very short rating scale for ADHD is unlikely to
identify the full range of symptoms associated with this
condition. Third, the use of web-based self-report instru-
ments made it possible to examine a large cohort of pa-
tients. Something that had been difficult had we chosen
more time-consuming diagnostic methods. However,
this also means that our results suffer from the validity
problems that accompany the use of self-report instru-
ments. Fourth, in a help seeking population like the
present one there could be a bias to overestimate symp-
toms. We have not controlled for the possibility that
such a bias is unevenly distributed in the different ED
diagnoses and thus distorting our results. Fifth, the assess-
ment methods used do not supply information that makes
it possible to control for other possible reasons for
ADHD-like symptoms, like personality or dissociative
disorders, learning disability or medical reasons. Thus, it
is not possible to rule out such symptoms as alternative
explanations to our results. Sixth, the cross sectional de-
sign of the study mean that we cannot establish a causal
link between ADHD symptoms and ED. Seventh, there is
a shift from restricting to bulimic ED diagnoses and also a
symptom shift in ADHD with increasing age, meaning
that our results may not be applicable for children and ad-
olescents. Eighth, the number of men were too small for
sub group statistics.
Conclusions
This prospective study, including a much larger patient
cohort than previous studies, supports earlier findings of
a high frequency of ADHD symptoms across separate
ED diagnoses, especially those with bingeing/purging
behaviors. The finding that patients with the bingeing/
purging subtype of AN have ASRS-results indicating a
possible ADHD on level with BN patients is new and in
need of replication. The study also lends further support
to recent observations of inattentive ADHD symptoms
being more prominent than hyperactivity/impulsivity
symptoms in adult female ED patients. Patients with BN,
BED, bulimic EDNOS and AN bingeing/purging subtype
might benefit from a better understanding of the con-
nections between their ADHD symptoms and their ED.
Further studies on the implications for this comorbidity
including controlled treatment trials with stimulants for
bingeing/purging ED are needed.
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